Fernández GO, Abreu PFA, Hernández PA, Santos SD, Ortiz RDL, Rojas RI

Language: Spanish
References: 19
Page: 17-24
PDF size: 210.03 Kb.

ABSTRACT

Objective: To describe the clinical and pathological characteristics of patients diagnosed with uveal melanoma.
Methods: A retrospective, descriptive and case series study was performed from January 2011 to June 2016 in the Institute of Oncology and Radiobiology of Cuba (INOR). The universe of study was the sample of 41 patients, all of them diagnosed with uveal melanoma and treated in this period of time. The study variables were age, sex, laterality, tumor location and tumor, classification, cell type, degree of invasion and treatment.
Results: Females accounted for 56.1 % of the sample. The patients aged 50 years or over (75.6 %) were the most affected whereas left eye was the most vulnerable (58.5 %). The main location were the choroids (75.6 %) According to size, the large tumors predominated (58.5 %); from the histological viewpoint, the most common cell-type was fusiform cell tumor (34.2 %); according to the degree of invasion, the sclera was the most affected (17 %) and the only treatment was enucleation.
Conclusions: Uveal melanoma is more frequently located in the choroids. It mainly appears in patients aged over 50 years and most of tumors are large.

REFERENCES

1. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110(5):956-61. 2. McLean IW, Saraiva VS, Burnier MN. Pathological and prognostic features of uveal melanomas. Canad J Ophthalmol. 2004;39(49:343-50.

2. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. A meta-an alysis of 5-year mortality rates following enucleation. 1966 through 1988. Arch Ophthalmol. 1992;110(2):245-50.

3. Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT. The American Brachitherapy Society Recomendations For Brachitherapy Of Uvela Melanomas. Radiat Oncol. 2003;56(2):544-55.

4. Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. Local treatment failure and enucleation in the first 5 years after brachytherapy. Ophthalmology. 2002;109(12):2197-206.

5. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol. 2005;23(31):8076-80.

6. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma. Arch Ophthalmol. 2005;123(12):1639-43.

7. Melgares Ramos MA, Santos Silva D, Puig Mora M, Cruz Mojarrieta J, Mesa Zárate E, Cordiés Justín N. Melanoma de coroides. Estudio de la casuística en el INOR en el período de 1980-1996. Rev Cubana Oncol. 1998;14(3):149-54.

8. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. 1998;125(6):745-66.

9. Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT, American Brachytherapy Society. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Intern J Rad Oncol Biol Phys. 2003;56(2):544-55.

10. Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am. 2005;18(1):75-84.

11. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309-15.

12. Missotten GS, Keunen JE. Screening for uveal melanoma metastasis. Literature review. Bull Soc belge d’Ophtalmol. 2004;(294):13-22.

13. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. Relationship of uveal nevi to malignant melanomas. Cancer. 1967;20(4):493-507.

14. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005; 112(10):1784-9.

15. Bell DJ, Wilson MW. Choroidal melanoma: natural history and management options. Cancer control: J Moff Canc Cent. 2004;11:296-303.

16. McLean IW, Ainbinder DJ, Gamel JW, McCurdy JB. Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location. Ophthalmology. 1995;102(7):1060-4.

17. Kaiserman I, Anteby I, Chowers I, Blumenthal EZ, Kliers I, Pe'er J. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Brit J Ophthalmol. 2004;88(7):892-5.

18. Lindegaard J, Isager P, Prause JU, Heegaard S. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern. Invest Ophthalmol Vis Scien. 2006;47(8):3268-75.

19. Lommatzsch PK, Kirsch IH. 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years. Doc Ophthalmol. 1988;68(3-4):225-38.